Dallas Scrip - 07 Nov 2025 Form 4 Insider Report for Marpai, Inc. (MRAI)

Reporting relationship: Chief Operating Officer
Issuer ticker: MRAI
Reported as of: 07 Nov 2025
Net transaction value: +$100,000
SEC form: 4
Accepted by SEC: 12 Nov 2025, 06:48:30 UTC
Prior SEC filing: 12 Jun 2025
Source filing: View source filing
Reporting owner signature: /s/ Dallas Scrip

Key filing fact

Dallas Scrip filed Form 4 for Marpai, Inc. (MRAI) on 12 Nov 2025.

Key facts

This page summarizes Dallas Scrip's Form 4 filing for Marpai, Inc. (MRAI).
2 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 12 Nov 2025, 06:48.

Change

Previous filing in this sequence was filed on 12 Jun 2025.
Current net transaction value: +$100,000.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0002069643 Primary reporting owner

Scrip Dallas

Relationship: Chief Operating Officer
Address: C/O MARPAI, INC., 615 CHANNELSIDE DRIVE, SUITE 207, TAMPA
Signature: /s/ Dallas Scrip
Signature date: 12 Nov 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

MRAI transaction

Class A Common Stock

Award

Transaction value: $100,000
Shares: +100,000
Change %
Price: $1.00
Shares after: 100,000
Date: 07 Nov 2025
Ownership: By Dallas S. Scrip and Michelle R. Script Trust
Footnotes: F1, F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

MRAI transaction Derivative

Common Warrants to purchase Shares of Common Stock

Purchase

Transaction value
Shares: +200,000
Change %
Price
Shares after: 200,000
Date: 07 Nov 2025
Ownership: By Dallas S. Scrip and Michelle R. Script Trust
Underlying class: Shares of Common Stock
Underlying amount: 200,000
Exercise price: $1.00
Footnotes: F1, F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Rule 10b5-1 trading plan

These transactions were reported as open-market trades under a Rule 10b5-1 plan. The plan lets an insider set trading instructions in advance, which can reduce the risk of trading while in possession of material nonpublic information.

Original filing language: transaction made pursuant to a contract, instruction, or written plan intended to satisfy Rule 10b5-1(c).

Explanation of responses 2 footnotes

Footnote F1

On November 7, 2025, Marpai Inc. (the "Company") entered into a Securities Purchase Agreement for a private placement offering, in which the reporting person purchased 100,000 shares of common stock of the Company and common warrants to purchase up to 200,000 shares of common stock of the Company. The purchase price for each share of common stock and accompanying common warrant is $1.00. The common warrants have an exercise price of $1.00 per share, can be exercised immediately following the closing of the private placement offering and will be exercisable for three years following the date of issuance.

Footnote F2

The securities are held by the Dallas S. Scrip and Michelle R. Script Trust, of which the reporting person and spouse are co-trustees and share investment and voting control.